· Preliminary Earnings
Q3 consolidated operating profit KRW 2.0 billion, down 9.4% YoY; net loss
Q3 consolidated revenue was KRW 14.8 billion, down 3.3% YoY and 6.1% QoQ, with operating profit of KRW 2.0 billion, down 9.4% YoY and up 22.4% QoQ.
049960 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Preliminary Earnings
Q3 consolidated revenue was KRW 14.8 billion, down 3.3% YoY and 6.1% QoQ, with operating profit of KRW 2.0 billion, down 9.4% YoY and up 22.4% QoQ.
Get app alerts for new disclosures from CELL BIOTECH CO ., LTD.